Randomized Clinical Trial
Copyright ©The Author(s) 2021.
World J Clin Cases. Dec 6, 2021; 9(34): 10604-10615
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10604
Table 3 Comparison of spatiotemporal parameters within group (between pre- and post-treatment) and among groups (between lower body positive pressure group and control group)

LBPP group
Control group
P1 value
P2 value
P3 value
P4 value
Pre-treatment
Post-treatment
Pre-treatment
Post-treatment
Stance phase (%)55.11 ± 3.1357.31 ± 2.3954.49 ± 3.3555.72 ± 2.600.0010.0960.6900.201
Swing phase (%)44.89 ± 3.1342.69 ± 2.3945.52 ± 3.3544.28 ± 2.60< 0.001< 0.0010.6900.197
Mean velocity(%height/s)57.64 ± 2.1064.28 ± 3.6457.72 ± 3.8459.33 ± 3.17< 0.001< 0.0010.9580.007
Cadence (steps/min)106.76 ± 3.22110.10 ± 2.84104.46 ± 4.35105.36 ± 3.580.0020.1410.2330.008
Stride length (m)0.46 ± 0.030.50 ± 0.180.47 ± 0.020.48 ± 0.230.0010.0250.3990.037
Step width (m)0.15 ± 0.010.15 ± 0.010.15 ± 0.010.15 ± 0.000.0800.3430.7530.854
Knee flex-extension (Degree)66.14 ± 5.4372.34 ± 5.3866.40 ± 5.2666.89 ± 5.330.0040.4000.9190.048